Post Data Before Child COVID Vaccine Schedule

Full Title:
Protecting Our Children from the CDC Act

Summary#

This bill would stop the Department of Health and Human Services (HHS) from putting any COVID‑19 vaccine on the child and adolescent immunization schedule until HHS posts all clinical data it holds about that vaccine’s safety and effectiveness on the CDC public website. It also immediately removes any COVID‑19 vaccine already on that schedule when the law starts. The stated goal is to require public posting of clinical data before COVID‑19 vaccines are recommended for children.

  • Main change: No COVID‑19 vaccine may be added to the child and adolescent immunization schedule unless HHS posts all clinical data in its possession about safety and efficacy on the CDC website, with personal health information and agency/sponsor personnel information deidentified.
  • Immediate effect: Any COVID‑19 vaccine on the schedule at enactment is deemed removed and must be administratively removed.
  • Replacement: The Secretary may put a vaccine back on the schedule only after the posting requirement is met and other laws are followed.
  • Scope: The “child and adolescent immunization schedule” means the Advisory Committee on Immunization Practices (ACIP) child and adolescent schedule.

What it means for you#

  • Parents and children: This could mean that COVID‑19 vaccines would not appear on the ACIP child and adolescent immunization schedule until HHS posts the required data. The bill itself does not directly change whether an individual child can receive a vaccine.
  • Health care providers (doctors, nurses): ACIP recommendations guide clinical practice. If a COVID‑19 vaccine is removed from that schedule, providers may face different guidance when advising patients. The bill does not direct clinicians how to act beyond the ACIP schedule change.
  • Schools and local public health authorities: The bill does not directly change state school vaccination laws. However, because many school rules and vaccine requirements reference the ACIP schedule, removal from that schedule could affect local policies. This is not specified in the bill and would depend on state and local actions.
  • Vaccine manufacturers and sponsors: HHS must post all clinical data in its possession about safety and efficacy before a vaccine can be placed on the schedule. The bill requires deidentification of personal health data and agency/sponsor personnel information, but it does not explain how proprietary or business-confidential information should be handled.
  • HHS, CDC, and ACIP: These agencies must collect, deidentify, and post all clinical data they possess before placing a COVID‑19 vaccine on the child and adolescent schedule. They must also remove any vaccine on that schedule as of enactment.

Expenses#

No publicly available information.

  • The bill text does not include a fiscal estimate or an explicit budget for posting or processing data.
  • Possible administrative costs (not estimated in the bill) could include staff time to locate data, remove identifiers, review for legal/confidentiality issues, and publish materials on the CDC website.
  • There may be legal or contract disputes if posting would disclose information claimed as confidential by manufacturers. The bill does not address compensation, litigation costs, or timelines.

Proponents' View#

The bill does not include separate statements from supporters. Based on the text, a likely intent and arguments for the bill are:

  • The bill appears intended to increase transparency by making clinical data on safety and effectiveness publicly available before a COVID‑19 vaccine is recommended for children.
  • Supporters may argue this could build public trust in vaccine recommendations by allowing independent review of the data HHS holds.
  • Requiring posting of data could be seen as promoting open access to government-held scientific information.

If specific public statements from bill sponsors or supporters are provided, those would supply clearer arguments. No such statements are included in the supplied material.

Opponents' View#

The bill text does not include formal criticisms. Based on what the bill would do, reasonable concerns or trade-offs include:

  • One concern is that automatically removing vaccines from the child and adolescent schedule at enactment could immediately change public-health guidance and possibly reduce vaccine uptake among children, depending on how providers, insurers, and states respond.
  • The bill does not define “all clinical data.” It is unclear which documents HHS must post (raw data, trial protocols, safety summaries, adverse event reports) and whether ongoing trial or proprietary information is excluded.
  • The requirement to post all data HHS possesses may conflict with legal protections for confidential commercial information. The bill does not explain how such disputes will be resolved.
  • Posting and deidentifying large amounts of clinical data could require significant staff time and technical work. The bill provides no funding or timeline for these tasks.
  • It is unclear whether removal from the ACIP schedule would affect insurance coverage, school requirements, or other practical matters that currently rely on ACIP recommendations. The bill does not address these downstream effects.